Creabilis logo

Creabilis

Europe, Emilia-Romagna, Italy, Samone

Description

Creabilis, a specialty pharmaceutical company focused on dermatology, discovers and develops new medicines for a range of skin disorders.

Investor Profile

Creabilis has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in France.
  • Strong thematic focus on Biopharma, Biotechnology, Therapeutics.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • France (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Creabilis frequently co-invest with?

Matignon Investissement & Gestion
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Rothschild & Co.
Europe, Ile-de-France, France, Paris
Co-Investments: 1
123Venture
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1

What are some of recent deals done by Creabilis?

Nautilus Biotech

Évry, Ile-de-France, France

Nautilus Biotech is a clinical-stage biopharmaceutical company focused on developing therapeutic proteins.

BiopharmaBiotechnologyTherapeutics
Series UnknownApr 30, 2007
Amount Raised: $11,300,000